FDA Inspection
Daniel C. Tarquinio, DODaniel C. Tarquinio, DO – FDA Inspection, Nov 5, 2021
Record Details
This FDA Inspection record concerns Daniel C. Tarquinio, DO, with an inspection on November 5, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Daniel C. Tarquinio, DO
- Inspection Date
- November 5, 2021
- Product Type
- Drugs
View Company Profile
ID · 8153d0f1-4fe0-4ab2-846d-e53cd48477fc
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1156040
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(a)Accountability records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Daniel C. Tarquinio, DO
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 23, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Daniel C. Tarquinio, DO
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.